In the context of finance, EBIT helps assess operational efficiency without tax and debt distortions; the latest market scan reveals biotech firms with average EBIT margins of 15%, hinting at strong pipeline monetization. Forbes does not accept payment for placement on lists. Consolidated order intake by value decreased to € 103.5 billion (2023: € 186.5 billion) with the consolidated order book valued at € 629 billion at the end of 2024 (year-end 2023: € 554 billion). The increase in the consolidated backlog value mainly reflects the Company-wide book-to-bill of above 1, and the strengthening of the US dollar. EBIT in finance remains a watch-list item for portfolio managers following health care REITs, which report 7.4% EBIT margin growth amid demographic-driven occupancy gains.